Albiotic 330 mg/100 mg Intramammary Solution
Albiotic 330 mg/100 mg Intramammary Solution
Authorised
- NEOMYCIN SULFATE
- Lincomycin hydrochloride
Product identification
Medicine name:
Albiotic 330 mg/100 mg Intramammary Solution
Active substance:
- NEOMYCIN SULFATE
- Lincomycin hydrochloride
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
NEOMYCIN SULFATE115.96/milligram(s)1.00Syringe
-
Lincomycin hydrochloride359.63/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary solution
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Meat and offal48hour
-
Milk72hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RF03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- Sterile aqueous solution in 10 ml high density polyethylene syringes with a fixed cannula (plastets), packaged as 100plastets in an outer cardboard box also containing alcohol pads for teat disinfection. Cap LDPE, brombutyl rubber stopper.
- Sterile aqueous solution in 10 ml high density polyethylene syringe with a fixed cannula (plastet), packaged as 1 plastet in an outer cardboard box also containing alcohol pad for teat disinfection. Cap LDPE, brombutyl rubber stopper.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Biovet AD
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10782/028/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 19/10/2025